The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: a systematic review and meta‐analysis
AJM Van De Sande, M Kengsakul… - … of Gynecology & …, 2024 - Wiley Online Library
Objective A major side effect of cervical excision for high‐grade cervical intraepithelial
neoplasia (CIN) is premature birth. A non‐invasive treatment for reproductive age women is …
neoplasia (CIN) is premature birth. A non‐invasive treatment for reproductive age women is …
Toll-Like Receptor Stimulation Enhances Phagocytosis and Intracellular Killing of Nonencapsulated and Encapsulated Streptococcus pneumoniae by Murine …
Toll-like receptors (TLRs) are crucial pattern recognition receptors in innate immunity that
are expressed in microglia, the resident macrophages of the brain. TLR2,-4, and-9 are …
are expressed in microglia, the resident macrophages of the brain. TLR2,-4, and-9 are …
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod
M Lapteva, M Mignot, K Mondon, M Möller… - European Journal of …, 2019 - Elsevier
Abstract mPEG-hexPLA micelles have shown their ability to improve delivery and cutaneous
bioavailability of a wide range of poorly water soluble and lipophilic molecules. Although …
bioavailability of a wide range of poorly water soluble and lipophilic molecules. Although …
Toll-Like Receptor Prestimulation Increases Phagocytosis of Escherichia coli DH5α and Escherichia coli K1 Strains by Murine Microglial Cells
S Ribes, S Ebert, D Czesnik, T Regen… - Infection and …, 2009 - Am Soc Microbiol
Meningitis and meningoencephalitis caused by Escherichia coli are associated with high
rates of mortality. When an infection occurs, Toll-like receptors (TLRs) expressed by …
rates of mortality. When an infection occurs, Toll-like receptors (TLRs) expressed by …
Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection
RB Pyles, D Higgins, C Chalk, A Zalar, J Eiden… - Journal of …, 2002 - Am Soc Microbiol
Synthetic oligonucleotides containing CpG motifs in specific sequence contexts have been
shown to induce potent immune responses. We have evaluated mucosal administration of …
shown to induce potent immune responses. We have evaluated mucosal administration of …
A review of topical imiquimod in the management of basal cell carcinoma, actinic keratoses, and other skin lesions
J Ryu, FC Yang - Clinical Medicine. Therapeutics, 2009 - journals.sagepub.com
Imiquimod (trade name Aldara™) is a small molecule of the imidazoquinoline family, a
group of nucleoside analogs that were first synthesized as potential antiviral agents. It has …
group of nucleoside analogs that were first synthesized as potential antiviral agents. It has …
[HTML][HTML] A perspective on imiquimod microneedles for treating warts
Warts are a common skin problem and are caused by infection with a virus. Warts are
currently mainly treated by therapies involving ablating tissue or interrupting cellular …
currently mainly treated by therapies involving ablating tissue or interrupting cellular …
Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
ML Diamantis, BL Bartlett, SK Tyring - Skin therapy letter, 2009 - europepmc.org
Imiquimod 5% cream (Aldara, Graceway Pharmaceuticals) is an immune response modifier
used for the topical treatment of anogenital warts in non-HIV-infected patients. Several …
used for the topical treatment of anogenital warts in non-HIV-infected patients. Several …
Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial
AJM van de Sande, R van Baars… - … Journal of Obstetrics …, 2024 - Wiley Online Library
Objective To investigate the efficacy of imiquimod in women with residual or recurrent
cervical intraepithelial neoplasia (rrCIN), compared with large loop excision of the …
cervical intraepithelial neoplasia (rrCIN), compared with large loop excision of the …
[HTML][HTML] Vitiligo-like depigmentation following treatment with imiquimod 5% cream for condylomata acuminata
M Alatabani, Y Ghobara, A Alissa - Case Reports in Dermatology, 2021 - karger.com
Imiquimod cream is an immunomodulatory agent that has been approved by the US Food
and Drug Administration for use in the treatment of anogenital warts (condylomata …
and Drug Administration for use in the treatment of anogenital warts (condylomata …